Atlas Trials

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

Clinical trial NCT04261907 · TERMINATED

Trial details

NCT number
NCT04261907
Sponsor
First Affiliated Hospital of Zhejiang University
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
2019-nCoV
Start date
2020-02-11
Primary completion
2020-04-13
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.